"Neurochirurgische Klinik des Universitätsklinikums Heidelberg"

During the past decade, Neurochirurggische Universitatsklinik des Heidelberg conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Neurochirurggische Universitatsklinik des Heidelberg" are "Aneurysmal Subarachnoid Hemorrhage" (2 trials). Many other conditions were trialed in "Neurochirurggische Universitatsklinik des Heidelberg" in a lesser frequency.

Most popular intervention types in "Neurochirurggische Universitatsklinik des Heidelberg" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Clazosentan" (1 trials), "Clazosentan 15 mg/h" (1 trials) and "Clazosentan 5 m/h" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurochirurggische Universitatsklinik des Heidelberg" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Neurochirurggische Universitatsklinik des Heidelberg". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Neurochirurggische Universitatsklinik des Heidelberg, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Neurochirurggische Universitatsklinik des Heidelberg, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".